Cardiac troponin T (hs-cTnT) can be used as a sensitive serological marker for the diagnosis of myocardial damage in people with normal renal function (4), but its levels vary across a considerable number of patients, who suffer end-stage renal disease (including dialysis patients), but show no clinical symptoms of MI (5, 6). This evidence concerns the gene TNNT2 and chronic kidney disease.